Capricor Therapeutics Inc. (NASDAQ: CAPR) shares jumped 13.54% to $9.73 in Wednesday pre-market trading amid the opening of the World Muscle Society’s 2026 congress, where Capricor’s late-breaking HOPE-3 open-label-extension poster on Deramiocel was available to registered delegates on the virtual platform.
The rally extended a sharp move that began after Tuesday’s regular session. CAPR closed at $8.57, down 1.61%, before rising to $10.28 in after-hours trading.
WMS opened its virtual congress platform to registered delegates on Sept. 29, and its programme lists late-breaking poster presentations as available online. Capricor’s poster covers a cross-phase delayed-start analysis and a two-year comparison with natural history. WMS’s press policy keeps late-breaking abstracts under embargo until the final day of the congress even when related content is accessible beforehand.
#Crypto
The rally extended a sharp move that began after Tuesday’s regular session. CAPR closed at $8.57, down 1.61%, before rising to $10.28 in after-hours trading.
WMS opened its virtual congress platform to registered delegates on Sept. 29, and its programme lists late-breaking poster presentations as available online. Capricor’s poster covers a cross-phase delayed-start analysis and a two-year comparison with natural history. WMS’s press policy keeps late-breaking abstracts under embargo until the final day of the congress even when related content is accessible beforehand.
#Crypto